Allogeneic bone marrow transplantation for infantile globoid-cell leukodystrophy (Krabbe's disease)

Pediatric Transplantation

Volumn 6, Issue 5, 2002, Pages 427-431

  Caniglia, Maurizio ^a   Rana, Ippolita ^a   Pinto, Rita Maria ^a   Fariello, Giuseppe ^a   Caruso, Roberta ^a   Angioni, Adriano ^a   Vici, Carlo Dionisi ^a   Sabetta, Gaetano ^a   De Rossi, Giulio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Allogeneic bone marrow transplantation; Galactocerebrosidase; Globoid cell leukodystrophy 'Krabbe's syndrome'

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM FUNCTION; CHIMERA; DETERIORATION; DISEASE SEVERITY; FEMALE; GLOBOID CELL LEUKODYSTROPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HYDROCEPHALUS; INFANT; LIVING DONOR; MUSCLE HYPOTONIA; ONSET AGE; STEM CELL TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

AGE OF ONSET; BONE MARROW TRANSPLANTATION; FATAL OUTCOME; FEMALE; GALACTOSYLCERAMIDASE; HUMANS; INFANT; LEUKOCYTES; LEUKODYSTROPHY, GLOBOID CELL;

EID: 0036802019     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.02026.x     Document Type: Article

References (21)

1. Andrews JM, Cancilla PA, Grippo J, Menkes JH. Globoid cell leukodystrophy (Krabbe's disease): Morphological and biochemical studies. Neurology 1971: 21: 337-352.
2. Suzuki K, Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): Deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci USA 1970: 66: 302-309.
3. Loonen MC, Van Diggelen OP, Janse HC, Kleijer WJ, Arts WF. Late-onset globoid cell leucodystrophy (Krabbe's disease). Clinical and genetic delineation of two forms and their relation to the early-infantile form. Neuropediatrics 1985: 16: 137-142.
4. Loes DJ, Peters C, Krivit W. Globoid cell leukodystrophy: Distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. Am J Neuroradiol 2000: 2: 316-323.
5. Darras B, Kwan ES, Gilmore HE, Ehrenberg BL, Rabe EF. Globoid cell leukodystrophy: Cranial computed tomography and evoked potentials. J Child Neurol 1986: 2: 126-130.
6. Shapiro EG, Lockman L, Kennedy W. Bone marrow transplantation as treatment for globoid cell leukodystrophy. In: Desnick, RJ, ed. Treatment of Genetic Disease. New York: Churchill Livingstone, 1991: 223-238.
7. Krivit W, Shapiro EG, Peters C, et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 1998: 16: 1119-1126.
8. Hoogerbrugge PM, Brouwer OF, Bordigoni P. Allogeneic bone marrow transplantation for lysosomal storage diseases. Lancet 1995: 354: 1398-1402.
9. Hoogerbrugge PM, Poorthuis BJHM, Romme AE, et al. Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest 1988: 81: 1790-1794,.
10. Bambach BJ, Moser HWM, Blakemore K, et al. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant 1997: 4: 399-402.
11. Kurtzberg J, Richards K, Wenger D, et al. Correction of Krabbe disease with neonatal hematopoietic-stem cell transplantation. Biol Blood Marrow Transplant 2002: 8: 97-98.
12. Krivit W, Aubourg P, Shapiro E, Peters C. Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 1999: 6: 377-382.
13. Krivit W, Peters C, Shapiro EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999: 2: 167-176.
14. Shapiro EG, Lockman LA, Balthazor M, Krivit W. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995: 18: 413-429.
15. Laxdal T, Hallgrimsson J. Krabbe's globoid cell leucodystrophy with hydrocephalus. Arch Dis Child 1974: 49: 232-234.
16. Krivit W, Sung JH, Shapiro EG, Lockman LA. Microglia the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage disease. Cell Transplant 1995: 4: 385-392.
17. Ichioka T, Kishimoto Y, Brennan S, Santos GW, Yeager AM. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse), effects on levels of galactosylceramidase, psychosine, and galactocerebrosides. Proc Natl Acad Sci USA 1987: 84: 4259-4263.
18. Peters C, Zanjanai E, Krivit W. Review of consideration for hematopoietic stem cell transplantation for storage disease both post-natal and in utero. Second International Meeting on in Utero Stem Cell Transplantation and Gene Therapy, Nottingham, UK, 1997: 1-3.
19. Luzi P, Rafi MA, Zaka M, Curtis M, Vanier MT, Wenger DA. Generation of a mouse with low galactocerebrosidase activity by gene targeting: A new model of globoid cell leukodystrophy (Krabbe disease) Mol Genet Metab 2001: 73: 211-223.
20. Wenger DA. Krabbe disease: genetic analysis and prospects for therapy. Krivit W, et al. Bone Marrow Transplantation as Effective Treatment of Central Nervous System in Patients With Lysosomal and Peroxisomal Enzyme Deficiences. II Congress On Rare Diseases. Genetic Disorders. Rome: Istituto Superiore Di Sanità, 2000.
21. Soper BW, Lessard MD, Vogler CA, et al. Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency. Blood 2001: 97: 1498-1504.